| Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models MJ McConnell, L Actis, J Pachón FEMS microbiology reviews 37 (2), 130-155, 2013 | 723 | 2013 |
| Biology of adenovirus and its use as a vector for gene therapy MJ McConnell, MJ Imperiale Human gene therapy 15 (11), 1022-1033, 2004 | 349 | 2004 |
| Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606T with Human Lung Epithelial Cells … JA Gaddy, BA Arivett, MJ McConnell, R López-Rojas, J Pachón, LA Actis Infection and immunity 80 (3), 1015-1024, 2012 | 278 | 2012 |
| Progress on the development of rapid methods for antimicrobial susceptibility testing MR Pulido, M García-Quintanilla, R Martín-Peña, JM Cisneros, ... Journal of Antimicrobial Chemotherapy 68 (12), 2710-2717, 2013 | 252 | 2013 |
| Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae A Olaya-Abril, R Prados-Rosales, MJ McConnell, R Martín-Peña, ... Journal of proteomics 106, 46-60, 2014 | 236 | 2014 |
| Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii MJ McConnell, C Rumbo, G Bou, J Pachón Vaccine 29 (34), 5705-5710, 2011 | 234 | 2011 |
| Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii R López-Rojas, J Domínguez-Herrera, MJ McConnell, F Docobo-Peréz, ... Journal of Infectious Diseases 203 (4), 545-548, 2011 | 181 | 2011 |
| High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as … J Nowak, E Zander, D Stefanik, PG Higgins, I Roca, J Vila, MJ McConnell, ... Journal of Antimicrobial Chemotherapy 72 (12), 3277-3282, 2017 | 175 | 2017 |
| Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii MJ McConnell, J Domínguez-Herrera, Y Smani, R López-Rojas, ... Infection and immunity 79 (1), 518-526, 2011 | 171 | 2011 |
| Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells Y Smani, MJ McConnell, J Pachón PloS one 7 (4), e33073, 2012 | 170 | 2012 |
| Emerging therapies for multidrug resistant Acinetobacter baumannii M García-Quintanilla, MR Pulido, R López-Rojas, J Pachón, ... Trends in microbiology 21 (3), 157-163, 2013 | 154 | 2013 |
| Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine MJ McConnell, J Pachón Vaccine 29 (1), 1-5, 2010 | 152 | 2010 |
| Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness R López-Rojas, MJ McConnell, ME Jiménez-Mejías, ... Antimicrobial agents and chemotherapy 57 (9), 4587-4589, 2013 | 102 | 2013 |
| Using bacterial genomes and essential genes for the development of new antibiotics FR Fields, SW Lee, MJ McConnell Biochemical pharmacology 134, 74-86, 2017 | 83 | 2017 |
| Characterization of a permissive epitope insertion site in adenovirus hexon MJ McConnell, X Danthinne, MJ Imperiale Journal of virology 80 (11), 5361-5370, 2006 | 71 | 2006 |
| First steps towards a vaccine against Acinetobacter baumannii M Garcia-Quintanilla, M R Pulido, M J McConnell Current pharmaceutical biotechnology 14 (10), 897-902, 2013 | 66 | 2013 |
| Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii M García-Quintanilla, M Carretero-Ledesma, P Moreno-Martínez, ... International journal of antimicrobial agents 46 (6), 696-702, 2015 | 65 | 2015 |
| Adenovirus-based prime-boost immunization for rapid vaccination against anthrax MJ McConnell, PC Hanna, MJ Imperiale Molecular Therapy 15 (1), 203-210, 2007 | 65 | 2007 |
| Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection M García-Quintanilla, MR Pulido, J Pachon, MJ McConnell PLoS One 9 (12), e114410, 2014 | 63 | 2014 |
| Where are we with monoclonal antibodies for multidrug-resistant infections? MJ McConnell Drug Discovery Today 24 (5), 1132-1138, 2019 | 59 | 2019 |
